Investors
FilamenTech is a biomedical company specializing in software development and experimental analysis in the field of human muscle research, drug discoveries and accurate personalized treatments.
We deliver end-to-end multiscale muscle modeling solutions with data analysis, develop strategies for effective treatment of myopathies, introduce new standards in experimental procedures and offer guidance in designing novel experiments.
Our MUSICO Platform can be used to reduce the cost and number of experiments for muscle drug research for muscles, reduce time to market for new drugs, reduce risk of failure and create better personalized treatment strategies.
Latest news
New NIH grant awarded
We are excited to announce FilamenTech’s participation in a new scientific project called “Analysis Tools for Fiber Diffraction of Muscle” (R01GM144555), supported by National Institute of General Med
02 January, 2023Collaboration with IIT and NASA
FilamenTech has recently started a collaboration with prof. Aleksandar G. Ostrogorsky from Illinois Institute of Technology, Chicago, IL, USA on performing simulations and data analysis for the optimi
02 January, 2023Successful completion of SilicoFCM EU project
Over the last 4 years, FilamenTech’s co-founders prof. Srboljub Mijailovich and Momcilo Prodanovic, along with FilamenTech’s scientific board members were involved in the project called “SilicoFCM
31 December, 2022
